Future clinical studies should determine which patient groups should be targeted as potential candidates for the symptomatic and/or neuroprotective effects of GLP-1RAs, to find out, whether combinations of GLP-1RA with other classes of drugs can further enhance their effectiveness, and evaluate their long-term effect on the course of the disease and side effects
To avoid degradation by DPP-4 and extend GLP-1's circulating half-life, several GLP-1 analogs are currently used
De Vivo DC, Bohan TP, Coulter DL, et al
Will continue I cant say enough great things about this company and ease of use, from start to finish
After Dosing Return the solid to cold, dry, desiccated, light-protected storage promptly